[Efficacy and safety of low-dose rituximab combined with different dosage of glucocorticoids for immune thrombocytopenia].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Volumn 34, Issue 5, 2013, Pages 409-412

  Xing, Wei wei ^a   Li, Zhen yu ^b   Yan, Zhi ling ^b   Liu, Kai ge ^b   Li, Ning ^b   Cao, Jiang ^b   Pan, Xiu ying ^b   He, Xu peng ^b   Xu, Kai lin ^b  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MONOCLONAL ANTIBODY; RITUXIMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; THROMBOCYTOPENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908393112     PISSN: 02532727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)